Amarin Corp Plc (AMRN)

[Whalatane]

Raggy ...thx , will chk out. . Biotech is often driven by near term catalysts ...which in AMRN's case might be the reimbursement decision in Italy ( Who they will cover and to what degree ) . In biotech RMB and I are in ARDX and UNCY ....both with near term catalysts ...high risk but U might want to chk out. Around 40% of my wife's dialysis patients never reach serum phosphorous goals on the current meds . In UNCY's trials 91 % were able to reach pho goals. . ARDX 's drug has also seen success with patients ,when existing meds failed.
Huge surprise in the AI field for me was / is APP. Bt it around $90 and assigned it my high school aged son at $110, provided he could explain to me what they were doing . Yikes
AMRN needs an APP like moment .
Good luck
Kiwi